Issues Archive

The most complete archive of clinical and pathology lab industry news available, including issues from 1997 to the present.

Volume XXV No. 1 – January 2, 2018

In this issue:

WHAT ARE THE ODDS for or against ACLA’s lawsuit against the Department of Health and Human Services? THE DARK REPORT has exclusive insight from two experienced lab industry attorneys to help lab managers better understand the likely paths that this litigation may take, and know how long it may take to come to a conclusion. Also, TDR is the first to alert readers that UnitedHealthcare is expanding the range of tests that will require pre-notification or prior-authorization in its controversial laboratory benefit management program in Florida.

View Issue TOC

Volume XXIV No. 17 – December 11, 2017

In this issue:

AT THE LAST MINUTE, the American Clinical Laboratory Association has filed suit to block implementation of the looming CLFS price cuts called for by Jan. 1, 2018 — cuts that are expected to be the single most financially-disruptive event in the clinical lab industry in two decades. THE DARK REPORT offers first analysis of this late-breaking story. Also, this issue includes a special look at “Top 10 Lab Stories of 2017” that are related to the impending price cuts.

View Issue TOC

Volume XXIV No. 16 – November 20, 2017

In this issue:

HERE AT THE DAWN of the new era of value-based healthcare, THE DARK REPORT has uncovered a new trend: The diverging paths of hospital labs and independent lab companies that will severely test the endurance of the independents, radically alter ancillary industries and create fierce new competition among specialty labs. Also in this issue is exclusive analysis of the possibility of upcoming Medicare Part B lab test fee cuts causing big lab companies to try to negotiate higher prices with private health insurers.

View Issue TOC

Volume XXIV No. 15 – October 30, 2017

In this issue:

IN THIS ISSUE, THE DARK REPORT breaks the news that growing numbers of hospitals are being asked to enter into a “hospital outpatient department” billing arrangement involving lab testing — arrangements that push the limits of federal and state statutes. One common attribute of these HOPD schemes is that the organizers want the hospital, as an in-network provider, to bill for all the lab tests performed in the organizers’ labs. The hospital and the HOPD organizers then split the payments from payers.

View Issue TOC

Volume XXIV No. 14 – October 9, 2017

In this issue:

IT’S TIME TO ACT: This issue of THE DARK REPORT is devoted entirely to the looming laboratory fee cuts called for by the Protection of Access to Medicare Act — driven by flawed data — that will cause “significant harm” to the lab industry and all patients who depend on it. This issue delivers exclusive analysis of the fast-approaching crisis, and urges pathologists and lab managers to submit comments to CMS by October 23, and also to contact Senators and Representatives, urging a delay in implementation of the fee cuts.

View Issue TOC

Volume XXIV No. 13 – September 18, 2017

In this issue:

IS THIS A SIGN that the rampant fraud and abuse within the toxicology laboratory testing sector may finally be seeing its day of reckoning by federal prosecutors, the media, and private payers? THE DARK REPORT reports on two such companies that have been accused of massive fraud and are are fighting to stay in business. At the same time, another toxicology lab has developed a DNA-authentication method that alerts the lab to cheaters on urine tests.

View Issue TOC

Volume XXIV No. 12 – August 28, 2017

In this issue:

THE ERROR MAY ONLY AFFECT A FEW PATIENTS, but Invitae’s failure to test for the Boland Inversion across some 50,000 patients may set a record for such an error. THE DARK REPORT broke the news of this mistake, and in this issue delivers analysis of the fallout, including the fact that Invitae’s assays are laboratory-developed tests (LDTs), which the FDA has been pushing to regulate for the past three years. Also in this issue, TDR discusses the costs for redoing genetic tests, and Invitae’s push to expand its market share.

View Issue TOC

Volume XXIV No. 11 – August 7, 2017

In this issue:

WITH ONLY A FEW MONTHS REMAINING before CMS implements lab fee cuts that will shake the industry to its core, THE DARK REPORT delivers exclusive analysis of the industry’s options to fight back, the reasons why the PAMA rule is flawed, and even how these flaws are believed to have developed when the Protecting Access to Medicare Act was passed in 2014.

View Issue TOC

Volume XXIV No. 10 – July 17, 2017

In this issue:

IN AN EXCLUSIVE INTERVIEW, Ambry Genetics’ CEO shares details about the clinical and market strategies that led Ambry to become the target for one of the biggest lab acquisition deals in recent years by purchase price, and one of the highest-priced acquisitions of a privately-held lab company. Also, laboratory executives and pathologists preparing for 2018’s looming $400 million in Medicare Part B fee cuts will learn from this issue about the inherent bias included in the PAMA final rule that will work to the disadvantage of their labs.

View Issue TOC

Volume XXIV No. 9 – June 26, 2017

In this issue:

FOR LAB MANAGERS WORRIED about being parceled out to a national lab, news reports that Quest Diagnostics had exited the long-running CompuNet Clinical Laboratory joint venture in Ohio is intriguing. THE DARK REPORT provides exclusive analysis of that news, provides a history of the lab joint venture, and considers the possibility of a trend in lab agreements with Quest. Also, this issue includes analysis of the trend in genetic testing pre-authorization and its impact on local labs.

View Issue TOC

Don’t Be at the Mercy of the Tumultuous Healthcare Revolution

Subscribe to The Dark Report for as little as $15.27 per week.

The Dark Report

Get the most expert business intelligence for clinical laboratories and pathology groups available today. Subscribe to The Dark Report.

		
test
test
Get web access of The Dark Report for only $19.12 per week.
Get web and tablet access of The Dark Report for only $19.12 per week.
Get digital and print editions of The Dark Report for only $22.97 per week.
Get a hard copy of The Dark Report delivered to your home for only $15.27 per week.
Enter Your Login Credentials
This setting should only be used on your home or work computer.

×